Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIGLUSTAT vs MILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIGLUSTAT vs MILNACIPRAN: Safety Overview

Metric MIGLUSTAT MILNACIPRAN
Total FAERS Reports 759 1,392
Deaths Reported 219 120
Death Rate 28.9% 8.6%
Hospitalizations 307 274
Average Patient Age 19.9 yrs 54.8 yrs
% Female Patients 48.2% 82.6%
FDA Approval Date Apr 17, 2018 Apr 22, 2016
Manufacturer ANI Pharmaceuticals, Inc. Cardinal Health 107, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription